1·The control group of cardiac glycosides and diuretics conventional treatment group on the basis of conventional therapy plus valsartan and carvedilol.
对照组用强心苷及利尿药常规治疗，治疗组在常规治疗基础上加用缬沙坦及卡维地洛。
2·Objective To investigate valsartan combined carvedilol in the treatment of chronic heart failure in the clinical efficacy and safety, provide a reference for clinical treatment.
目的探讨缬沙坦联合卡维地洛在治疗慢性心力衰竭中的临床疗效及安全性，为临床治疗提供参考。
3·Patients taking carvedilol were 22% less likely to develop new onset diabetes than patients taking metoprolol, the authors report.
据报道，服用卡维地洛的患者新发糖尿病的可能性比服用美托洛尔者低22%。
4·Objective To investigate the effects of carvedilol, irbesartan and their combination on myocardial collagen network remodeling after acute myocardial infarction (AMI) in rats.
目的研究卡维地洛、厄贝沙坦及二者合用对急性心肌梗死(ami)大鼠胶原网络重构的影响。
5·AIM: To investigate the effects of carvedilol on His-bundle electric activity and cardiac electric activity in anaesthetized rabbits.
目的：研究卡维地洛对麻醉兔希氏束电活动和心电活动的影响。